MedTrace Logo

Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer

NCT00002689 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2013-07-18

No results posted yet for this study

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy combined with chemotherapy may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of brachytherapy followed by external-beam radiation therapy plus chemotherapy in treating patients who have pancreatic cancer that cannot be removed surgically.

Conditions

Interventions

DRUG

dexamethasone

DRUG

fluorouracil

RADIATION

brachytherapy

RADIATION

phosphorus P32

RADIATION

radiation therapy

Sponsors & Collaborators

  • Center for Molecular Medicine

    lead OTHER

Principal Investigators

  • Stanley E. Order, MD, ScD, FACR · Center for Molecular Medicine

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-09-30
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002689 on ClinicalTrials.gov